-
Policy Critique: Ueda et al. On Japan’s COVID-19 Vaccine Public Health Response
Editorial This issue features the third entry in a growing category of peer-reviewed scholarship in Science, Public Health Policy & the…
-
EPA Backtracks on Protecting Kids From Dangerous Pesticide Used on Food
By Beyond Pesticides On Sept. 16, the U.S. Environmental Protection Agency (EPA)…
-
The Biosecurity Industry Fights Back: national security is at stake without our mRNA vaccines. Here is all you need to see this is utter fabrication
Here is why a chorus insists that mRNA vaccines are a military…
-
What Is Leucovorin? FDA Announces New Autism Treatment, Sparking Enthusiasm, Calls for Caution
By Michael Nevradakis, Ph.D. The FDA will approve leucovorin, a medication used…
Editor’s Choice
About the Journal
This initiative exists to help insure that policies in public health practice and law are founded on a full consideration of available knowledge derived by robust science. From Dr Lyons-Weiler: “While IPAK will continue to conduct basic, clinical and translational biomedical research in a completely unbiased manner, and will pubish results regardless of the outcome, it will also be increasingly centered on questions of policy and law that impact public health, laws that impact public health, and cases and rulings that impact the citizen’s expression of self-governance through law. We’re putting the Public back into Public Health.”